Skip to main content
  1. Right Decisions
  2. DGRefHelp - NHS Dumfries & Galloway
  3. Sexual health
  4. Pregnancy related
  5. Back
  6. Pregnancy - STIs and group B (GBS) streptococcal colonisation
  7. Introduction
Important: please update your RDS app to version 4.7.3 Details with newsletter below.

Please update your RDS app to v4.7.3

We asked you in January to update to v4.7.2.  After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. 

To update to the latest release:

 On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Right Decision Service newsletter: February 2025

Welcome to the February 2025 update from the RDS team

1.     Next release of RDS

 

A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:

 

  • Fixes to mitigate the recurring glitches with the RDS admin area and the occasional brief user interface outages which have arisen following implementation of the new distributed technology infrastructure in December 2024.

 

  • Capability to embed content from Google calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream into RDS pages.

 

  • Capability to include simple multiplication in RDS calculators.

 

The release will also incorporate a number of small fixes, including:

  • Exporting of form within Medicines Sick Day Guidance in polypharmacy toolkit
  • Links to redundant content appearing in search in some RDS toolkits
  • Inclusion of accordion headers alongside accordion text in search result snippets.
  • Feedback form on mobile app.
  • Internal links on mobile app version of benzo tapering tool

 

We will let you know when the date and time for the new release are confirmed.

 

2.     New RDS developments

There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.

The Benzodiazepine tapering tool is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.

3.     Archiving and version control and new RDS Search and Browse interface

Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.

4.     Statistics

At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .

 

5.     Review of content past its review date

We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.

 

6.     Toolkits in development

Some important toolkits in development by the RDS team include:

  • National CVD prevention pathways – due for release end of March 2025.
  • National respiratory pathways, optimal cancer diagnostic pathways and cancer prehabilitation pathways from the Centre for Sustainable Delivery. We will shortly start work on the national cancer referral pathways, first version due for release via RDS around end of June 2025.
  • HIS Quality of Care Review toolkit – currently in final stages of quality assurance.

 

The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.

 

7. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 28th February 12-1 pm
  • Tuesday 11th March 4-5 pm

 

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

Introduction

Many STIs (Sexually Transmitted Infections) can adversely affect the fetus and be more troublesome in pregnancy.

This guidance is designed to:

  • highlight important issues about the impact of common STIs on the pregnant woman and her child who may be exposed either in utero or during the birthing process.
  • highlight any management recommendations which may be different in pregnancy compared to the non pregnant state. This guideline should be used in conjunction with the guideline specific to the STI in question.

It is beyond the remit of this guideline to advise on the management of HIV and hepatitis B during pregnancy.

Group B Streptococcus (GBS) is recognised as the most important cause of severe early onset infection in newborn babies. GBS is not a sexually transmitted infection but since maternal Group B Streptococcal carriage in pregnancy is 50% guidance is included to assist with the management of pregnant woman in whom GBS is considered to be an incidental finding.

General points

  • Discuss with the client the advantages of details regarding a diagnosis of an STI being included within her maternity record and where permission is granted inform her obstetric team.
  • The physiology of pregnancy can alter the natural history of an STI.
  • It is safe to perform vaginal examination in the pregnant woman, and to take cervical swabs.
  • No woman should be given doxycycline, quinolones (for example ciprofloxacin, ofloxacin) or treated with podophyllotoxin or imiquimod preparations unless the clinician is assured she is at no risk of pregnancy.
  • Partner notification is essential to reduce the possibility of re-infection of a pregnant woman (and unborn child).
  • It should not be assumed that every women presenting with a diagnosis or symptoms suggestive of an STI in pregnancy has had HIV/syphilis testing as part of antenatal testing. She may have opted out of testing or not yet had her booking bloods and testing should be offered. Even for women tested earlier in the pregnancy for HIV and syphilis the diagnosis of an STI may indicate repeat HIV and syphilis testing is warranted.
  • Patients planning a pregnancy should also be encouraged to be tested for HIV and syphilis.
  • The finding of GBS in the vagina or urine of a woman who is pregnant is significant and this information needs to be shared with the obstetric team involved in her care.